C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators Included is a dedicated polycystic kidney disease track alongside investments in brain health, pediatrics, and rare diseases. TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today officially launched its 2026 global Request for…
The start of the new year has been busy with activity in the health policy world. ACIP has continued to narrow vaccine recommendations, with hepatitis A and B, rotavirus, influenza, meningococcal, and RSV vaccines no longer routinely recommended. The Affordable Care Act premium subsidies were allowed to expire at the…
Thank you for your interest in accessing our exclusive content. Please note that this section is reserved for ASPN members only. If you're already a member, please log in using your credentials to unlock access using the button below.
If you're not yet a member or if your membership has expired, don't worry! You can easily sign up or renew your membership to gain immediate access to all our valuable resources and benefits.
To sign up or renew your membership, simply click here "Sign Up" or "Renew Membership", and follow the instructions.
Thank you for your interest in accessing our exclusive content. Please note that this section is reserved for ASPN members only. If you're already a member, please log in using your credentials to unlock access using the button below.
If you're not yet a member or if your membership has expired, don't worry! You can easily sign up or renew your membership to gain immediate access to all our valuable resources and benefits.
To sign up or renew your membership, simply click here "Sign Up" or "Renew Membership", and follow the instructions.
Thank you for your interest in accessing our exclusive content. Please note that this section is reserved for ASPN members only. If you're already a member, please log in using your credentials to unlock access using the button below.
If you're not yet a member or if your membership has expired, don't worry! You can easily sign up or renew your membership to gain immediate access to all our valuable resources and benefits.
To sign up or renew your membership, simply click here "Sign Up" or "Renew Membership", and follow the instructions.
This request for applications is to provide pilot funding to early-stage investigators in the PKD field and established investigators who are new to PKD research. About The Polycystic Kidney Disease Research Resource Consortium (PKD RRC) The goal of the PKD RRC (pkd-rrc.org) is to accelerate discovery in the field of…
Composed of over 21,000 physicians and scientists, ASN is the world’s largest professional society devoted to the study of kidney disease. ASN holds several programs to expand and support the nephrology workforce, including Kidney Tutored Research and Education for Kidney Scholars (TREKS). Kidney TREKS fosters an interest in nephrology through a…
Thank you for your interest in accessing our exclusive content. Please note that this section is reserved for ASPN members only. If you're already a member, please log in using your credentials to unlock access using the button below.
If you're not yet a member or if your membership has expired, don't worry! You can easily sign up or renew your membership to gain immediate access to all our valuable resources and benefits.
To sign up or renew your membership, simply click here "Sign Up" or "Renew Membership", and follow the instructions.
Dr. Drake is a pediatric nephrologist at UT Southwestern Medical Center. Her research focuses on using genetically engineered mouse models to understand how disruptions in normal kidney development drive Wilms tumorigenesis. Given that the underlying mechanisms of how Wilms tumors originate from renal progenitor cells and can “hijack” developmental programs…
